Premium
Methamphetamine enhances Hepatitis C virus replication in human hepatocytes
Author(s) -
Ye L.,
Peng J. S.,
Wang X.,
Wang Y. J.,
Luo G. X.,
Ho W. Z.
Publication year - 2008
Publication title -
journal of viral hepatitis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 100
eISSN - 1365-2893
pISSN - 1352-0504
DOI - 10.1111/j.1365-2893.2007.00940.x
Subject(s) - methamphetamine , interferon , innate immune system , hepatitis c virus , stat protein , virology , stat1 , biology , interferon regulatory factors , immunology , virus , immune system , pharmacology , signal transduction , stat3 , microbiology and biotechnology
Summary. Very little is known about the interactions between hepatitis C virus (HCV) and methamphetamine, which is a highly abused psychostimulant and a known risk factor for human immunodeficiency virus (HIV)/HCV infection. This study examined whether methamphetamine has the ability to inhibit innate immunity in the host cells, facilitating HCV replication in human hepatocytes. Methamphetamine inhibited intracellular interferon alpha expression in human hepatocytes, which was associated with the increase in HCV replication. In addition, methamphetamine also compromised the anti‐HCV effect of recombinant interferon alpha. Further investigation of mechanism(s) responsible for the methamphetamine action revealed that methamphetamine was able to inhibit the expression of the signal transducer and activator of transcription 1, a key modulator in interferon‐mediated immune and biological responses. Methamphetamine also down‐regulated the expression of interferon regulatory factor‐5, a crucial transcriptional factor that activates the interferon pathway. These in vitro findings that methamphetamine compromises interferon alpha‐mediated innate immunity against HCV infection indicate that methamphetamine may have a cofactor role in the immunopathogenesis of HCV disease.